Alexander Werner

Chief Business Officer
The Biosimilars Group

Alexander Werner is Chief Business Officer at The Biosimilars Group since May 2018. He is responsible for business development and for the supervision of integrated biosimilar projects.
Alexander has 18 years of experience in drug development holding various managerial positions in developing biotechs and as business developer of service providers with a strong focus on the preclinical phase of biologics. Prior to his current position he was consultant for regulatory affairs at Granzer, co-founder of the biotech spin-off Imevax and contributed as responsible project manager to the transition of an academic vaccine project into clinical testing. Alexander graduated in biology and holds a PhD (summa cum laude) in neurobiology from the Max-Planck-Institute.